Michael Ackermann - Net Worth and Insider Trading
Michael Ackermann Net Worth
The estimated net worth of Michael Ackermann is at least $50 Million dollars as of 2024-05-17. Michael Ackermann is the Director of Tarsus Pharmaceuticals Inc and owns about 1,304,016 shares of Tarsus Pharmaceuticals Inc (TARS) stock worth over $50 Million. Details can be seen in Michael Ackermann's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Ackermann has not made any transactions after 2022-05-05 and currently still holds the listed stock(s).
Transaction Summary of Michael Ackermann
Michael Ackermann Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Ackermann owns 2 companies in total, including Tarsus Pharmaceuticals Inc (TARS) , and Oyster Point Pharma Inc (OYST) .
Click here to see the complete history of Michael Ackermann’s form 4 insider trades.
Insider Ownership Summary of Michael Ackermann
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2022-05-05 | director & 10 percent owner |
| OYST | Oyster Point Pharma Inc | 2019-10-30 | director |
Michael Ackermann Latest Holdings Summary
Michael Ackermann currently owns a total of 1 stock. Michael Ackermann owns 1,304,016 shares of Tarsus Pharmaceuticals Inc (TARS) as of May 5, 2022, with a value of $50 Million.
Latest Holdings of Michael Ackermann
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2022-05-05 | 1,304,016 | 38.58 | 50,308,937 |
Holding Weightings of Michael Ackermann
Michael Ackermann Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Ackermann has made a total of 9 transactions in Tarsus Pharmaceuticals Inc (TARS) over the past 5 years, including 1 buys and 8 sells. The most-recent trade in Tarsus Pharmaceuticals Inc is the acquisition of 100,000 shares on May 5, 2022, which cost Michael Ackermann around $1 Million.
Insider Trading History of Michael Ackermann
- 1
Michael Ackermann Trading Performance
GuruFocus tracks the stock performance after each of Michael Ackermann's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Ackermann is 41.91%. GuruFocus also compares Michael Ackermann's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Ackermann within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Ackermann's insider trading performs compared to the benchmark.
Performance of Michael Ackermann
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.94 | | | | | |
| Relative Return to S&P 500(%) | 15.86 | | | | | |
Michael Ackermann Ownership Network
Michael Ackermann Owned Company Details
What does Tarsus Pharmaceuticals Inc do?
Who are the key executives at Tarsus Pharmaceuticals Inc?
Michael Ackermann is the director & 10 percent owner of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include Chief Human Resources Officer Dianne C. Whitfield , General Counsel Bryan Wahl , and Chief Commercial Officer Aziz Mottiwala .
Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary
Over the past 18 months, Michael Ackermann made no insider transaction in Tarsus Pharmaceuticals Inc (TARS). Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 329,867 shares made by Bobak R. Azamian , a net sale of 26,966 shares made by Leonard M. Greenstein , and a net sale of 18,404 shares made by Bryan Wahl .
In summary, during the past 3 months, insiders sold 28,810 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 28,810 shares. During the past 18 months, 421,985 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 411,479 shares.
Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tarsus Pharmaceuticals Inc Insider Transactions
Michael Ackermann Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Ackermann. You might contact Michael Ackermann via mailing address: 202 Carnegie Center, Suite 109, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
